64º
wjxt logo
    • News
    • Watch Live
    • Local News
    • Florida
    • Georgia
    • National
    • Coronavirus
    • FluVaxJax
    • Your Voice Matters
    • Politics
    • I-Team
    • Trust Index
    • Community
    • SnapJAX
    • Health
    • Money
    • Education
    • Consumer
    • Entertainment
    • Weird News
    • Weather
    • Weather News
    • SnapJAX
    • Skycams
    • Alerts
    • Hurricanes
    • Plan and Prepare
    • Georgia
    • St. Augustine
    • Surf and Tides
    • Environment
    • Forecasting Change
    • News4JAX+
    • Watch Live
    • News4JAX Insider
    • How To Watch News4JAX+
    • The Morning Show
    • River City Live
    • This Week In Jacksonville
    • Solutionaries
    • Something Good
    • TV Listings
    • Sports
    • Sports Videos
    • Jaguars
    • Jaguars Stats
    • News4JAGS Podcast
    • Gators Breakdown
    • Gators Stats
    • Football Friday
    • V4rsity Podcast
    • All Star Athlete
    • Features
    • News4JAX Insider
    • Positively JAX
    • River City Live
    • Deals4JAX
    • News4JAX+
    • Look Local
    • 4 Your Info
    • Travel
    • Black History Month
    • Healthy Heart
    • Valentine's Day
    • Podcasts
    • Community Calendar
    • Jacksonville Image Awards
    • Food & Recipes
    • Live Healthy
    • Contests
    • Talking Health
    • Pets
    • uSay Voting
    • CW17
    • CW Program Guide
    • Bounce
    • Traffic
    • SnapJAX
    • Skycams
    • Jax Best
    • Food
    • Activities
    • Shopping
    • Places
    • Newsletters
    • Sign Up For Newsletters
    • Contact
    • Careers at WJXT/WCWJ
    • SnapJAX
    • Meet the Team
    • Advertise with us
  • News
  • Weather
  • News4JAX+
  • Sports
  • Features
  • CW17
  • Traffic
  • Jax Best
  • Newsletters
  • Contact
News4JAX.com
  • News
  • Weather
  • News4JAX+
  • Sports
  • Features
  • CW17
  • Traffic
  • Jax Best
  • Newsletters
  • Contact
  • LIVE

Watch The 10 O'Clock News

The day's top local, national and international stories plus breaking news, weather and sports brought to you by the News4JAX team.

A river flood warning in effect for Brantley County

See the complete list

LIVE

Watch The 10 O'Clock News

A river flood warning in effect for Brantley County

PFIZER


17 hours ago

COVID test kits, treatments and vaccines won't be free to many consumers much longer

Insurers, employers, taxpayers and other consumers will all be affected as drugmakers move these products to the commercial market in May. How much you'll pay depends on your health insurance.

npr.org

U.S. plans to stop buying Covid shots for the public this fall. Here's what that means

Under the Affordable Care Act, most Americans would still get their Covid shots for free once the vaccine program goes commercial.

cnbc.com

California won't require COVID vaccine to attend schools

California won’t make children get the coronavirus vaccine to attend schools.

NOT REAL NEWS: A look at what didn't happen this week

None of these are legit, even though they were shared widely on social media. CLAIM: House Republicans are requiring Rep. Jamie Raskin, a Democrat from Maryland, to remove the headwear he’s donned on the House floor while undergoing chemotherapy. THE FACTS: Republicans have made no such request and have in fact been nothing but supportive, a spokesperson for Raskin told the AP.

news.yahoo.com

DC Studios boss James Gunn sinks cancel culture effort against star: Don’t keep a list of ‘what people think’

DC Studios co-head James Gunn defended "Shazam" star Zachery Levi after the actor prompted a backlash for criticizing COVID-19 vaccine manufacturer Pfizer.

foxnews.com

The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion

Sales of Paxlovid surged to $18.9 billion in 2022 which was the first full-year that the antiviral pill was available.

cnbc.com

Pfizer expects 2023 sales to decline by as much as 33% compared with record-breaking 2022

The pharmaceutical company booked $100.3 billion for full-year 2022, an all-time high.

cnbc.com

TUCKER CARLSON: If you really want to understand how powerful Big Pharma is, consider this

Fox News host Tucker Carlson exposes Pfizer's alleged manipulation of the COVID-19 virus as many suffer from the pandemic on "Tucker Carlson Tonight."

foxnews.com

FDA advisors recommend replacing original Covid vaccine with bivalent omicron shots for all doses

The Food and Drug Administration's independent advisory committee on Thursday unanimously recommended replacing Pfizer and Moderna's original Covid vaccine used in the U.S. for everyone's first two immunizations with the new bivalent omicron shots. Instead, the drugmakers' bivalent omicron shots that target the omicron BA.5 subvariant as well as the original strain would be used for the entire vaccination series. Currently, Pfizer's and Moderna's omicron shots are only authorized as a booster, while the first two doses are still their old shots based on the original Covid strain. The FDA has proposed moving to a system that resembles how the agency updates and rolls out flu shots every year. The agency would select a Covid vaccine formulation in June to target the variant that is expected to dominate in the fall and winter.

cnbc.com

FDA doesn't see increased risk of stroke for seniors who received Pfizer's omicron booster

Preliminary CDC data indicated a possible stroke risk following simultaneous administration of the Pfizer Covid booster and the flu vaccine.

cnbc.com

Stocks making the biggest moves premarket: Southwest, Tesla, Las Vegas Sands and more

These are the stocks posting the largest moves in premarket trading.

cnbc.com

Omicron booster shots provide some protection against mild illness from Covid XBB subvariants, CDC says

The CDC study published Wednesday provides the first estimate of the omicron shots' real-world effectiveness against the XBB family of subvariants. For people ages 18 to 49, the omicron booster reduced the risk of mild illness by about 48% two to three months after receiving the shot. The shots provided 38% protection against mild illness for those ages 50 to 64 and 42% protection for people ages 65 and older, according to the study. They had very little protection against mild illness due to waning immunity observed with the old vaccines, Link-Gelles said. It's too early to draw conclusions about how the protection from the omicron boosters holds up over time, she said.

cnbc.com

Stocks making the biggest moves premarket: Goldman, Pfizer, Cheesecake Factory, Alibaba and more

These are the stocks posting the largest moves premarket.

cnbc.com

CDC says it’s ‘very unlikely’ Pfizer booster carries stroke risk for seniors after launching review

The CDC said one of its monitoring systems detected a preliminary safety signal for stroke in people ages 65 and older who received the Pfizer omicron booster.

cnbc.com

CDC, FDA see possible link between Pfizer’s bivalent shot and strokes

The agencies said the surveillance signal “is very unlikely” to represent a “true clinical risk” and said they continued to recommend the vaccine.

news.yahoo.com

CDC identifies possible 'safety concern' for certain people receiving COVID vaccines

The CDC has identified a "safety signal" in the Bivalent Pfizer-BioNTech and is investigating whether the shot creates an increased stroke risk for people 65 and older.

foxnews.com

Elon Musk casts doubt on whether a 2nd COVID booster helps or hurts. Here’s what studies show.

Twitter owner and CEO Elon Musk waded into a discussion about COVID-19 boosters in a tweet on Wednesday, with the billionaire claiming that it “isn’t clear whether, all things considered, a second booster helps or hurts.”

news.yahoo.com

Andrew Bridgen: What has suspended MP said about vaccines?

The Conservative MP has been suspended after a tweet comparing Covid vaccine side effects to the Holocaust.

bbc.co.uk

Twitter Files: Pfizer board member Dr. Scott Gottlieb flagged tweets questioning COVID vaccine

Alex Berenson was the latest writer to be tapped by Elon Musk to dive into Twitter's archives, showing Dr. Scott Gottlieb, a Pfizer board member, targeting vaccine skepticism.

foxnews.com

Pfizer's Paxlovid not included in China's national insurance

China will not include Pfizer’s COVID-19 treatment drug in a national reimbursement list that would have allowed patients to get it at a cheaper price, saying it was too expensive.

BioNTech says it will start cancer vaccine trials in the UK from September

The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.

cnbc.com

Covid in China: People rush to book travel as borders finally reopen

But Chinese tourists will not have unfettered access to all countries - as some impose restrictions.

bbc.co.uk

BioNTech-Pfizer COVID vaccine sent to China for Germans

Germany has dispatched a batch of the BioNTech-Pfizer COVID-19 vaccine to China, where it will be administered to Germans who live in the country

washingtonpost.com

Vaccine researcher Dr. Robert Malone reinstated on Twitter after being banned over COVID misinformation policy

Robert Malone, an mRNA vaccine researcher, has returned to Twitter after being banned from the platform over its coronavirus misinformation policy.

foxnews.com

Why Isn't There An RSV Vaccine?

In a press release Pfizer says its maternal shot was 69% effective in preventing severe RSV infection in infants 0-6 months.

newsy.com

The FDA clears updated COVID-19 vaccines for kids under age 5

The decision aims to better protect the littlest kids amid an uptick in COVID-19 cases around the country. The Centers for Disease Control and Prevention is expected to sign off soon.

npr.org

FDA authorizes bivalent COVID-19 booster shots for children under 5

The FDA on Thursday approved the use of updated COVID-19 vaccines for children younger than 5, three days after Pfizer-BioNTech applied for an emergency use authorization.

foxnews.com

FDA clears updated COVID-19 vaccines for kids under age 5

U.S. regulators have cleared doses of the updated COVID-19 vaccines for children younger than 5.

FDA authorizes Covid omicron vaccines for children as young as 6 months old

The FDA's decision to authorize the shots for the youngest kids comes as Covid infections and hospitalizations are increasing nationally.

cnbc.com

FDA expected to decide on Pfizer RSV vaccine for older adults by May 2023

Pfizer said the FDA has accepted its RSV vaccine candidate for review under an expedited process that reduces the approval process by four months.

cnbc.com

Omicron boosters are weaker against BQ.1.1 subvariant that is rising in U.S., study finds

The boosters did not trigger a robust response against BQ.1.1. People with a prior history of infection who received the booster had a stronger response

cnbc.com

Pfizer asks FDA to clear updated COVID shot for kids under 5

Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5.

Omicron boosters probably aren't very effective against mild Covid illness, but will likely prevent hospitalizations, experts say

The study did not look at hospitalization, but experts believe the omicron booster shots will provide strong protection against severe outcomes.

cnbc.com

Omicron BQ Covid variants that threaten people with compromised immune systems are now dominant in U.S.

The BQ coronavirus subvariants are likely resistant to key antibody medications used by people with compromised immune systems.

cnbc.com

Pfizer says omicron booster is better against new subvariants like BQ.1.1 than old shots

Pfizer said the booster triggered more antibodies against omicron BQ.1.1, BA.4.6, BA.2.75.2 and XBB.1 in adults older than 55 compared to the original vaccines.

cnbc.com

Indian Health Service steps up COVID, other vaccine push

The Indian Health Service says all tribal members covered by the federal agency will be offered a vaccine at every appointment, when appropriate.

Nearly 2% of healthy infants hospitalized with RSV before first birthday, study finds

A study published in Lancet Respiratory Medicine found that 1.8% of healthy infants are hospitalized with RSV before their first birthday.

cnbc.com

We Finally Have Some Paxlovid Covid Data. Now We Need More.

A study of health records for 60,000 patients suggests the treatment might be useful in preventing long Covid, but the conclusion is far from certain.

washingtonpost.com

Pfizer releases more data indicating omicron boosters are better than old Covid shots

People older than 55 who received the new Covid booster had about four times more antibodies targeting omicron BA.5 than people who received the old vaccine.

cnbc.com

Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics

CEO Albert Bourla said Pfizer is staring down an expected loss of up to $18 billion in revenue from 2025 through 2030 as patent protections expire.

cnbc.com

Stocks making the biggest moves midday: Uber, Abiomed, Peloton, Carvana, Molson Coors and more

These are the stocks posting the largest moves in midday trading Tuesday, Nov. 1.

cnbc.com

Pfizer raises 2022 earnings guidance, beats third-quarter expectations

Pfizer now expects earnings per share of $6.40 to $6.50 for the year, up from its previous forecast of $6.30 to $6.45.

cnbc.com

Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data shows

Pfizer said it will submit an application to the Food and Drug Administration for the RSV vaccine's approval by the end of 2022.

cnbc.com

FDA says two studies showing omicron boosters weren't much better than old Covid shots were too small to come to any conclusions

The FDA pushed back against two independent studies that found the new boosters don't trigger a better immune response than the old shots.

cnbc.com

Pfizer says COVID-19 vaccine will cost $110-$130 per dose

Pfizer will charge $110 to $130 for a dose of its COVID-19 vaccine once the U.S. government stops buying the shots.

FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or Moderna

Novavax's Covid shots rely on protein technology used in other vaccines for decades, rather than the messenger RNA used in the Pfizer and Moderna vaccines.

cnbc.com

We Need to Build a Better Flu Shot

More people would roll up their sleeves for the flu vaccine if it were more reliably effective.

washingtonpost.com

Omicron-specific Covid boosters appear to work well, new data says—regardless of the side effects you experience

Experts and new data suggest the new omicron-specific Covid boosters work well — regardless of if you experience moderate, mild or no side effects at all.

cnbc.com

How much better are updated COVID boosters? Pfizer announces first results in human clinical trial

New findings are the first released from human clinical trials examining the bivalent booster shots that have been rolled out across the country.

cbsnews.com

Pfizer says omicron shots substantially boosted antibodies against BA.5 subvariant in early human data

The FDA has authorized Pfizer's boosters without direct human data on how they perform against the omicron BA.5 subvariant.

cnbc.com

U.S. Clears Updated COVID Boosters For Kids As Young As 5 Years Old

The boosters, rolled out for Americans 12 and older last month, are doses modified to target today's most common and contagious Omicron relatives.

newsy.com

US authorizes updated COVID-19 boosters for children as young as 5

The U.S. on Wednesday authorized updated COVID-19 boosters for children as young as 5

FDA clears updated COVID boosters for kids

The U.S. is seeking to expand protection ahead of an expected winter wave.

chicagotribune.com

Omicron boosters for kids 5-12 are cleared by the FDA. The CDC's OK is the last step

Tweaked boosters rolled out for Americans 12 and older last month, modified to target today's most common and contagious variant. The latest move may expand protection before an expected winter wave.

npr.org

FDA clears updated COVID boosters for kids as young as 5

The U.S. is about to offer updated COVID-19 booster shots to kids as young as 5.

FDA authorizes Covid omicron booster shots for kids as young as 5 years old

The Centers for Disease Control and Prevention still has to issue its recommendations before pharmacies can administer the new shots to kids.

cnbc.com

Covid vaccination linked to slight increase in menstrual cycle, NIH study confirms

A change in menstrual cycle length of eight days or less is considered within the normal range of variation, according to NIH.

cnbc.com

Pfizer or Moderna: Which new omicron-specific Covid booster should you get?

Americans have two options for getting a new omicron-specific Covid booster shot: Pfizer or Moderna. Which one should you get? Here's what experts say.

cnbc.com

Pfizer seeks to expand omicron booster to 5- to 11-year-olds

Pfizer is asking the Food and Drug Administration to expand use of its updated COVID-19 booster shot to children ages 5 to 11.

Israel rolls out new omicron-tailored COVID-19 vaccines

Israel has started administering doses of the new COVID-19 vaccine tailored to fight the highly infectious omicron variant.

EU regulator clears Pfizer-BioNTech's tweaked COVID booster

The European Medicines Agency has recommended the authorization of a tweaked booster dose of the Pfizer-BioNTech coronavirus vaccine that includes protection against two of the latest versions of omicron, as countries look to bolster their immunization programs ahead of winter.

CDC rolls out new vaccine booster to target Omicron variant ahead of the fall season

The Center for Disease Control and Prevention is recommending an additional COVID-19 booster shot that targets the Omicron variant.

EXPLAINER: Should you get a new COVID booster? If so, when?

New COVID-19 boosters targeting today’s most common omicron strains should begin arriving within days.

CDC endorses updated COVID boosters, shots to begin soon

New COVID-19 boosters that target today's most common omicron strains are set to begin soon.

EU regulator clears tweaked versions of COVID vaccines

The European Medicines Agency has recommended the authorization of two coronavirus vaccines made by Pfizer-BioNTech and Moderna Inc., tweaked to include protection against an early version of the omicron variant.

White House: How about a COVID-19 boost with that flu shot?

The Biden administration hopes to make getting a COVID-19 booster as routine as going in for the yearly flu shot.

California won't expand teen vaccines without parental OK

California won't allow teens age 15 and up to be vaccinated against the coronavirus without their parents' consent.

US clears updated COVID boosters targeting newest variants

U.S. regulators have authorized updated COVID-19 boosters, the first to directly target today's most common omicron strain.

Pfizer asks EU drug regulator to OK tweaked COVID vaccine

Pharmaceuticals Pfizer and BioNTech say they have asked the European Medicines Agency to authorize their updated coronavirus booster vaccine that includes the most recent omicron subvariants.

Tweaked COVID boosters close but how much will they help?

COVID-19 vaccines tweaked to better match today’s omicron threat are expected to roll out in a few weeks but how much will they help.

Study: Pfizer COVID pill showed no benefit in younger adults

Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults.

Pfizer COVID shots appear 73% effective in children under 5

Pfizer’s says its COVID-19 vaccine was 73% effective in protecting children younger than 5 as omicron spread in the spring.

Pfizer seeks OK of updated COVID vaccine booster for fall

Pfizer has asked U.S. regulators to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives.

Major test of first possible Lyme vaccine in 20 years begins

Researchers are seeking thousands of volunteers in the U.S. and Europe to test the first potential vaccine against Lyme disease in 20 years.

BioNTech reports strong first half, expects demand to grow

BioNTech, which teamed with Pfizer to develop a powerful COVID-19 vaccine, has reported higher revenue and net profit in the first half of the year.

US rules out summer COVID boosters to focus on fall campaign

U.S. regulators say they are no longer considering authorizing second COVID-19 booster shots for all adults under 50 this summer.

UK to offer 4th COVID-19 vaccine shot to all 50 and over

Everyone in Britain who is 50 or over will be offered a fourth dose of coronavirus vaccine in the fall, lowering the age threshold from the previously announced 65.

US regulators OK new COVID-19 shot option from Novavax

The U.S. is getting another COVID-19 vaccine choice.

Biden Administration calling for approval of 2nd COVID booster shot for adults

The ever-changing biology of COVID-19 means another booster shot may be necessary to keep people protected.

US allows pharmacists to prescribe Pfizer's COVID pill

U.S. pharmacists can now prescribe the leading COVID-19 pill directly to patients.

For now, wary US treads water with transformed COVID-19

The fast-changing coronavirus has kicked off summer in the U.S. with lots of infections but relatively few deaths compared to its prior incarnations.

Tweaked COVID boosters in US must target newer omicron types

U.S. regulators are telling COVID-19 vaccine makers to tweak any booster doses intended for fall so they protect against the newest omicron relatives.

FDA advisers debate updating COVID booster shots for fall

Government advisers are debating if Americans should get a modified COVID-19 booster shot this fall — one that better matches more recent virus variants.

FDA advisers debate updating COVID booster shots for fall

Government advisers are debating if Americans should get a modified COVID-19 booster shot this fall — one that better matches more recent virus variants.

US grapples with whether to modify COVID vaccine for fall

U.S. health authorities are facing a critical decision: whether to offer new COVID-19 booster shots this fall that are modified to better match the latest changes of the shape-shifting coronavirus.

Pfizer says tweaked COVID-19 shots boost omicron protection

Pfizer says tweaking its COVID-19 vaccine to better target the omicron variant is safe and boosts protection.

COVID vaccines saved 20M lives in 1st year, scientists say

Scientists estimate that nearly 20 million lives were saved worldwide by COVID-19 vaccines during their first year.

White House officials encourage parents to vaccinate their younger children

The White House COVID-19 response team is urging parents to get their young children vaccinated as the country begins to rollout vaccines to the youngest population.

Experts endorse Moderna COVID-19 shots for kids ages 6 to 17

An expert panel backed a second COVID-19 vaccine option for kids ages 6 to 17.

The FDA has authorized Covid-19 vaccines for children under 5. Will you be vaccinating your child?

Will you be vaccinating your child?

US opens COVID vaccine to little kids, shots begin next week

U.S. health officials have opened COVID-19 vaccines for infants, toddlers and preschoolers — the last group without the shots.

FDA authorizes 1st COVID-19 shots for infants, preschoolers

U.S. regulators have authorized the first COVID-19 shots for infants and preschoolers.

FDA advisers endorse 1st COVID-19 shots for kids under 5

The first COVID-19 shots for infants, toddlers and preschoolers in the U.S. have moved a step closer.

FDA advisers back Moderna’s COVID-19 vaccine for older kids

A government advisory panel has endorsed a second brand of COVID-19 vaccine for school-age children and teens.

Marathon US hearings to decide fate of COVID shots for tots

Next week brings a marathon of hearings as the U.S. decides whether to open COVID-19 vaccinations to kids under 5.

Officials: Millions of COVID-19 shots ordered for youngest

White House officials say orders have been coming in for COVID-19 vaccine doses for small children.

What’s the difference between the Novavax vaccine and others? A doctor breaks it down

Now that an FDA advisory committee has recommended the Novavax COVID-19 vaccination for emergency use, experts say we could possibly see the FDA give full approval of the vaccine soon.

FDA advisers back Novavax COVID shots as 4th US option

A more traditional kind of COVID-19 vaccine is a step closer to becoming the fourth option for U.S. adults.

White House: 1st shots for kids under 5 possible by June 21

The Biden administration says children under 5 may be able to get their first COVID-19 vaccination doses as soon as June 21, if federal regulators authorize shots for the age group as expected.

Pfizer to offer low-cost medicines, vaccines to poor nations

Pfizer says it will provide nearly two dozen products at not-for-profit prices in some of the world’s poorest countries.

  • TV Listings
  • Contact Us
  • Email Newsletters
  • RSS Feeds
  • Contests and Rules
  • Closed Captioning / Audio Description
  • Careers at WJXT / WCWJ
  • Terms of Use
  • WJXT Public File
  • WCWJ Public File
  • FCC Applications
  • Privacy Policy
  • Do Not Sell My Info
Follow Us
facebook
twitter
instagram
rss
Get Results with Omne
Omne Results Logo

If you need help with WJXT’s or WCWJ's FCC public inspection file, call (904) 393-9801.


Graham Media Group LogoGraham Digital Logo

Copyright © 2023 News4JAX.com is managed by Graham Digital and published by Graham Media Group, a division of Graham Holdings.